Insider Transactions

Print Print page     Email Email page

Date Name Title Type Shares Traded Price Range
Sep 1, 2009 facet biotech corp Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 22, 2009 thompson peter a Officer Option Execute 126,387 0.31
Mar 10, 2009 stromatt scott Officer Statement of Ownership 0 n/a
Sep 5, 2008 mann david a Director Buy 1,600 4.27
Sep 4, 2008 mann david a Director Buy 1,400 4.20
Sep 3, 2008 mann david a Director Buy 1,000 4.15
Mar 12, 2008 burge daniel j Officer Statement of Ownership 0 n/a
Mar 12, 2008 mckereghan kathleen Officer Statement of Ownership 0 n/a
Mar 12, 2008 mohler kendall Officer Statement of Ownership 0 n/a
Nov 20, 2007 mann david a Director Buy 4,000 10.00
Nov 19, 2007 thompson peter a Officer Buy 5,000 9.84 - 10.13
Dec 1, 2006 mann david a Director Buy 1,935 18.35 - 18.88
Nov 29, 2006 mann david a Director Buy 3,000 18.50
Oct 23, 2006 Fhm III, Llc Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,155,688 n/a
Oct 23, 2006 gillis steven Director Acquisition (Non Open Market) 2,288,486 n/a
Oct 23, 2006 Gillis, Steven PH.d. Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,288,486 n/a
Oct 23, 2006 heron patrick j Director Acquisition (Non Open Market) 2,155,688 n/a
Oct 23, 2006 hove anders d Director Buy 35,181 13.00
Oct 23, 2006 hove anders d Director Acquisition (Non Open Market) 1,822,451 n/a
Oct 23, 2006 oxford bioscience partners iv lp Beneficial Owner (10% or more) Acquisition (Non Open Market) 2,155,686 n/a
Showing 1-20 of 44 transactions Page: 1 2 3  See Next 20

Stock transaction information provided by EDGAR Online. Trubion Pharmaceuticals, Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. This listing does not include non-monetary transactions, such as stock option grants or shares purchased through the employee stock purchase plan. For recent transactions including non-monetary transactions, see our Section 16 SEC filings page.